Jazz Pharmaceuticals

Longitude Capital closes second life sciences fund with $385M

Friday, October 12, 2012 12:13 PM

Longitude Capital has closed the Longitude Venture Partners II, a $385 million venture capital fund dedicated to investments in drug development and medical technology. 

More... »


Jazz Pharmaceuticals to sell women's health business to Meda

Friday, September 7, 2012 10:31 AM

Jazz Pharmaceuticals, a specialty pharmaceutical company based in Dublin, has inked an agreement to sell its women's health business to Meda, an international specialty pharmaceutical company based in Sweden, for $95 million in cash.

More... »


Jazz to acquire EUSA Pharma for $650 million

Friday, April 27, 2012 01:21 PM

Jazz Pharmaceuticals has agreed to acquire EUSA Pharma, a privately-held, specialty pharmaceutical company with headquarters in the U.S. and U.K., for $650 million in cash and a potential $50 million milestone payable in cash based upon its lead product, Erwinaze, achieving a specified U.S. net sales target in 2013.

More... »

Jazz makes management appointments

Monday, January 30, 2012 02:28 PM

Jazz Pharmaceuticals, a biopharmaceutical company specializing in products that address unmet medical needs, has appointed the following individuals to senior management positions:

More... »

Jazz and Azur merge to form Jazz Pharmaceuticals

Friday, January 20, 2012 10:48 AM

Jazz Pharmaceuticals and Azur Pharma have completed their business combination, creating Jazz Pharmaceuticals plc, a specialty biopharmaceutical company based in Dublin, Ireland. 

More... »

Tobias joins Jazz Pharmaceuticals

Wednesday, September 28, 2011 11:16 AM

Jazz Pharmaceuticals has named Jeffrey Tobias, MD, senior vice president of research & development and chief medical officer, effective October 17.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.